The announcement by the United States that it’s cutting support to Gavi, the Vaccine Alliance’s work to vaccinate children in lower-income countries, put a damper on the organization’s high-level pledging event last week in Brussels, Belgium. The U.S. provides the organization with about 13% of its funding — some $300 million annually.
“We are very hopeful that they will come back,” Dr. Sania Nishtar, Gavi’s chief executive officer, said during a Devex event on the sidelines of the Fourth International Conference on Financing for Development, or FfD4, in Sevilla, Spain.
Under the Biden administration, the U.S. pledged to provide at least $1.58 billion to support Gavi’s work from 2026 through 2030.
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Sara Jervingsarajerving
Sara Jerving is a Senior Reporter at Devex, where she covers global health. Her work has appeared in The New York Times, the Los Angeles Times, The Wall Street Journal, VICE News, and Bloomberg News among others. Sara holds a master's degree from Columbia University Graduate School of Journalism where she was a Lorana Sullivan fellow. She was a finalist for One World Media's Digital Media Award in 2021; a finalist for the Livingston Award for Young Journalists in 2018; and she was part of a VICE News Tonight on HBO team that received an Emmy nomination in 2018. She received the Philip Greer Memorial Award from Columbia University Graduate School of Journalism in 2014.
